Latham & Watkins Advises NATO Innovation Fund as Lead Investor on Inbiome’s US$16M Series A

"Latham & Watkins advised the NATO Innovation Fund (NIF) as a lead investor on Inbiome’s US$16 million Series A round. The funding, co-led by NIF and a consortium led by Michiel Boehmer and Slingshot Ventures, backs the Dutch molecular diagnostics company. The Latham team was led by London corporate partner Shing Lo, with associates Toni Adejuyigbe and Kathleen Teo."

Latham & Watkins advised the NATO Innovation Fund (NIF), the lead investor in the transaction. The deal was a US$16 million Series A funding round in Inbiome, a Dutch molecular diagnostics company redefining microbiology testing; the round was co‑led by NIF and a consortium led by Michiel Boehmer and Slingshot Ventures. Lawyers from Latham & Watkins involved: Shing Yuin Lo (London corporate partner; team lead). Also involved were associates Toni Adejuyigbe and Kathleen Teo. (The press release specifies Shing Lo’s seniority and corporate practice area; no practice areas were provided for the associates.)

Menu

Latham & Watkins Advises NATO Innovation Fund as Lead Investor on Inbiome’s US$16M Series A

Read the full story

Menu

Latham & Watkins Advises NATO Innovation Fund as Lead Investor on Inbiome’s US$16M Series A

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads